TerminatedPHASE2, PHASE3NCT01597518

Riluzole in Spinal Cord Injury Study

Studying Spinal cord injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AOSpine North America Research Network
Principal Investigator
Michael Fehlings, MD, PhD
University Health Network, Toronto, Canada
Intervention
Riluzole(drug)
Enrollment
193 target
Eligibility
18-75 years · All sexes
Timeline
20132020

Study locations (29)

Collaborators

AO Foundation, AO Spine · United States Department of Defense · Rick Hansen Institute · Christopher Reeve Paralysis Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01597518 on ClinicalTrials.gov

Other trials for Spinal cord injury

Additional recruiting or active studies for the same condition.

See all trials for Spinal cord injury

← Back to all trials